GLI1 and cancer: It's interesting to note that though both MS-0022 and GDC-0449, and to a certain degree cyclopamine, led to a reduction of GLI1 mRNA in SUIT-2 cells in vitro, suggesting the possibility to affect autocrine Hh signaling in this cancer cell line.